• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅱ类 HLA 基因型与暴发性 1 型糖尿病:一项全国性调查及谷氨酸脱羧酶抗体的参考

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies.

机构信息

Department of Internal Medicine (I), Osaka Medical College.

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University.

出版信息

J Diabetes Investig. 2012 Feb 20;3(1):62-9. doi: 10.1111/j.2040-1124.2011.00139.x.

DOI:10.1111/j.2040-1124.2011.00139.x
PMID:24843547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4014934/
Abstract

UNLABELLED

Aims/Introduction:  Fulminant type 1 diabetes is a subtype of type 1 diabetes characterized by a remarkably abrupt onset of insulin-deficient hyperglycemia within a few days. The aim of the present study was to clarify characteristic class II HLA genotypes in a large number of patients with fulminant type 1 diabetes to date.

MATERIALS AND METHODS

We analyzed the HLA-DRB1 and DQB1 genotypes, and their haplotypes in 207 patients with fulminant type 1 diabetes and 325 control subjects in the Japanese population.

RESULTS

The frequencies of the DRB104:05-DQB104:01 and DRB109:01-DQB103:03 haplotypes were significantly higher, and those of the DRB101:01-DQB105:01, DRB115:02-DQB106:01 and DRB108:03-DQB106:01 haplotypes were significantly lower in patients with fulminant type 1 diabetes than in the control subjects. Combination analysis showed that the frequencies of homozygotes with DRB104:05-DQB104:01 [odds ratio (OR) 7.0] and DRB109:01-DQB103:03 (OR 9.5) were significantly higher in patients with fulminant type 1 diabetes. Within a limited portion of patients with fulminant type 1 diabetes with antibodies to glutamic acid decarboxylase (GADab; n = 25), the frequency of DRB109:01-DQB103:03, but not DRB104:05-DQB104:01, was significantly higher than in control subjects (44.0% vs 13.7%; Pc < 0.05, OR 5.0). [Correction to last line of RESULTS, added after online publication 29 July 2011: "OR 5.1" is changed to "OR 5.0".]

CONCLUSIONS

Our large-scale study showed the characteristic class II HLA genotypes in fulminant type 1 diabetes, and implicated that genetic contribution to disease susceptibility is distinct between GADab-positive and GADab-negative fulminant type 1 diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00139.x, 2012).

摘要

目的/引言:暴发性 1 型糖尿病是 1 型糖尿病的一个亚型,其特征为在数天内出现胰岛素缺乏性高血糖的显著急剧发作。本研究的目的是阐明迄今为止大量暴发性 1 型糖尿病患者的特征性 II 类 HLA 基因型。

材料和方法

我们分析了 207 例暴发性 1 型糖尿病患者和 325 名日本对照者的 HLA-DRB1 和 DQB1 基因型及其单倍型。

结果

DRB104:05-DQB104:01 和 DRB109:01-DQB103:03 单倍型的频率显著升高,而 DRB101:01-DQB105:01、DRB115:02-DQB106:01 和 DRB108:03-DQB106:01 单倍型的频率在暴发性 1 型糖尿病患者中显著降低。组合分析显示,DRB104:05-DQB104:01(比值比[OR]7.0)和 DRB109:01-DQB103:03(OR 9.5)纯合子的频率在暴发性 1 型糖尿病患者中显著升高。在暴发性 1 型糖尿病伴谷氨酸脱羧酶(GADab)抗体的有限部分患者中(n=25),DRB109:01-DQB103:03 的频率显著高于对照组(44.0% vs 13.7%;Pc<0.05,OR 5.0)。[对结果部分的最后一行进行更正,在线发表 2011 年 7 月 29 日之后添加:"OR 5.1"更改为"OR 5.0"。]

结论

我们的大规模研究显示了暴发性 1 型糖尿病的特征性 II 类 HLA 基因型,并提示疾病易感性的遗传贡献在 GADab 阳性和 GADab 阴性暴发性 1 型糖尿病之间存在差异。(糖尿病研究与临床实践,doi:10.1111/j.2040-1124.2011.00139.x,2012)。

相似文献

1
Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies.Ⅱ类 HLA 基因型与暴发性 1 型糖尿病:一项全国性调查及谷氨酸脱羧酶抗体的参考
J Diabetes Investig. 2012 Feb 20;3(1):62-9. doi: 10.1111/j.2040-1124.2011.00139.x.
2
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.与三种 1 型糖尿病亚型(暴发性、缓慢进展性和急性发作性)相关的 HLA 差异。
Diabetologia. 2009 Dec;52(12):2513-21. doi: 10.1007/s00125-009-1539-9. Epub 2009 Oct 8.
3
Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.自身免疫性糖尿病的遗传异质性:成人发病年龄受HLA DRB1和DQB1基因型影响(英国前瞻性糖尿病研究43)。英国前瞻性糖尿病研究(UKPDS)小组。
Diabetologia. 1999 May;42(5):608-16. doi: 10.1007/s001250051202.
4
Genetics of fulminant type 1 diabetes.暴发性1型糖尿病的遗传学
Ann N Y Acad Sci. 2006 Oct;1079:24-30. doi: 10.1196/annals.1375.004.
5
Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.非胰岛素依赖型谷氨酸脱羧酶(GAD)自身抗体阳性糖尿病的临床及遗传特征:日本全国性调查
PLoS One. 2016 May 13;11(5):e0155643. doi: 10.1371/journal.pone.0155643. eCollection 2016.
6
Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.埃及1型糖尿病儿童的风险基因与自身抗体——HLA-DRB1*04:05-DQA1*03-DQB1*02风险单倍型携带者中自身抗体的低频率
Diabetes Metab Res Rev. 2015 Mar;31(3):287-94. doi: 10.1002/dmrr.2609. Epub 2014 Nov 24.
7
The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region).HLA II类易感/保护性单倍型的分布可以部分解释意大利大陆(拉齐奥地区)1型糖尿病的低发病率。
Tissue Antigens. 2001 Dec;58(6):385-94. doi: 10.1034/j.1399-0039.2001.580607.x.
8
HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes.HLA风险单倍型:儿童1型糖尿病中的胰岛素缺乏
Rev Invest Clin. 2016 May-Jun;68(3):128-36.
9
Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.突尼斯人群中由人类白细胞抗原DRB1和DQB1基因编码的自身免疫性1型糖尿病遗传易感性
Clin Vaccine Immunol. 2009 Aug;16(8):1146-50. doi: 10.1128/CVI.00105-09. Epub 2009 Jun 24.
10
Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies.肿瘤坏死因子微卫星多态性影响携带DRB1*1502-DQB1*0601等位基因且具有抗谷氨酸脱羧酶抗体的成年发病糖尿病患者胰岛素依赖的发生。
J Clin Endocrinol Metab. 2000 Sep;85(9):3348-51. doi: 10.1210/jcem.85.9.6842.

引用本文的文献

1
Rapid Onset of Fulminant Type 1 Diabetes 10 Days After the First Dose of Nivolumab: A Case Report.首次使用纳武单抗10天后暴发性1型糖尿病快速发病:一例报告
Cureus. 2025 Jun 13;17(6):e85957. doi: 10.7759/cureus.85957. eCollection 2025 Jun.
2
A Case of Fulminant Type 1 Diabetes With Residual Insulin Secretion.一例伴有残余胰岛素分泌的暴发性1型糖尿病病例。
Cureus. 2025 Apr 21;17(4):e82751. doi: 10.7759/cureus.82751. eCollection 2025 Apr.
3
Sintilimab-induced diabetes mellitus and thyroid dysfunction in patient with gastric adenocarcinoma: A case report and literature review.信迪利单抗致胃腺癌患者糖尿病和甲状腺功能障碍:一例报告及文献复习
Medicine (Baltimore). 2025 May 16;104(20):e42490. doi: 10.1097/MD.0000000000042490.
4
Immune checkpoint inhibitor-related type 1 diabetes mellitus with closely monitored dynamics of glutamic acid decarboxylase antibody levels before and after disease onset.免疫检查点抑制剂相关的1型糖尿病,发病前后密切监测谷氨酸脱羧酶抗体水平的动态变化。
Diabetol Int. 2025 Feb 10;16(2):427-431. doi: 10.1007/s13340-025-00795-0. eCollection 2025 Apr.
5
A Case of Pancreatic Metastasis of Renal Cancer Coexisting With a Pancreatic Neuroendocrine Tumor in a Patient Diagnosed With Fulminant Type 1 Diabetes Mellitus.一名暴发性1型糖尿病患者同时存在肾癌胰腺转移与胰腺神经内分泌肿瘤的病例
Cureus. 2025 Feb 23;17(2):e79489. doi: 10.7759/cureus.79489. eCollection 2025 Feb.
6
New-onset Fulminant Type 1 Diabetes Following COVID-19 Vaccination.新冠疫苗接种后新发暴发性1型糖尿病
Intern Med. 2025 Jun 1;64(11):1691-1695. doi: 10.2169/internalmedicine.5053-24. Epub 2025 Mar 22.
7
Immune checkpoint inhibitor-related type 1 diabetes incidence, risk, and survival association.免疫检查点抑制剂相关的1型糖尿病发病率、风险及生存关联。
J Diabetes Investig. 2025 Feb;16(2):334-342. doi: 10.1111/jdi.14362. Epub 2024 Nov 21.
8
A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis.免疫检查点抑制剂相关糖尿病综述:发病机制、临床特征、治疗和预后。
Front Immunol. 2024 Nov 4;15:1448728. doi: 10.3389/fimmu.2024.1448728. eCollection 2024.
9
Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature.2019冠状病毒病疫苗接种后发生的1型糖尿病:两例报告及文献综述
Diabetol Int. 2024 Feb 29;15(3):577-582. doi: 10.1007/s13340-024-00695-9. eCollection 2024 Jul.
10
Case of new-onset fulminant type 1 diabetes mellitus accompanied by autoimmune thyroid disease after SARS-CoV-2 infection.新型冠状病毒感染后新发暴发性1型糖尿病伴自身免疫性甲状腺疾病病例。
Diabetol Int. 2024 May 30;15(3):621-626. doi: 10.1007/s13340-024-00729-2. eCollection 2024 Jul.

本文引用的文献

1
Report of the committee on the classification and diagnostic criteria of diabetes mellitus.糖尿病分类和诊断标准委员会报告。
J Diabetes Investig. 2010 Oct 19;1(5):212-28. doi: 10.1111/j.2040-1124.2010.00074.x.
2
Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.在中国,暴发型 1 型糖尿病与经典 1 型糖尿病在临床和自身免疫特征上有明显不同。
Diabetes Metab Res Rev. 2011 Jan;27(1):70-8. doi: 10.1002/dmrr.1148. Epub 2010 Nov 10.
3
Fulminant type 1 diabetes associated with pregnancy: a report of 2 cases from Malaysia.与妊娠相关的暴发性 1 型糖尿病:来自马来西亚的 2 例报告。
Diabetes Res Clin Pract. 2010 Nov;90(2):e30-2. doi: 10.1016/j.diabres.2010.08.009. Epub 2010 Sep 15.
4
Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes.TLRs 在初发暴发性 1 型糖尿病患者胰腺中的表达。
Endocr J. 2010;57(3):211-9. doi: 10.1507/endocrj.k09e-291. Epub 2009 Dec 12.
5
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.与三种 1 型糖尿病亚型(暴发性、缓慢进展性和急性发作性)相关的 HLA 差异。
Diabetologia. 2009 Dec;52(12):2513-21. doi: 10.1007/s00125-009-1539-9. Epub 2009 Oct 8.
6
A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: a comparison with a nationwide survey in Japan.韩国 29 例暴发型 1 型糖尿病患者的汇总分析:与日本全国性调查的比较。
Diabetes Res Clin Pract. 2009 Dec;86(3):e43-5. doi: 10.1016/j.diabres.2009.09.003. Epub 2009 Sep 25.
7
Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.肠道病毒感染、CXC趋化因子配体10(CXCL10)与CXCR3通路:暴发性1型糖尿病中β细胞加速衰竭的机制
Diabetes. 2009 Oct;58(10):2285-91. doi: 10.2337/db09-0091. Epub 2009 Jul 29.
8
A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody.1例因血清中和抗体水平升高而诊断为柯萨奇B4病毒感染的暴发性1型糖尿病病例。
Diabetes Res Clin Pract. 2009 Jun;84(3):e50-2. doi: 10.1016/j.diabres.2009.03.009. Epub 2009 Apr 10.
9
Fulminant type 1 diabetes in Caucasians: A report of three cases.白种人中的暴发性1型糖尿病:三例报告。
Diabetes Metab. 2008 Nov;34(5):529-32. doi: 10.1016/j.diabet.2008.05.003. Epub 2008 Oct 1.
10
Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients.日本患者中CTLA4基因对暴发性糖尿病和1A型糖尿病易感性的贡献差异。
Diabetes Care. 2008 Aug;31(8):1608-10. doi: 10.2337/dc08-0280. Epub 2008 Apr 28.